New Stem Cell Treatment that Benefits Diabetics

Diabetics who suffer from diabetic peripheral neuropathy may benefit from a new type of stem cell preparation, says a new study published in STEM CELLS Translational Medicine.

Diabetic peripheral neuropathy, or nerve damage, causes pain or loss of feeling in the toes, feet, legs, hands, and arms among diabetic patients. About 70 percent of diabetes suffer from neuropathy. Current treatments for severe diabetic peripheral neuropathy include tricyclic antidepressants, anticonvulsants, opioids, serotonin and norepinephrine reuptake inhibitors, and topical agents.
“However, none of these therapies directly targets the inflammation, most have negative side effects and less than 30 percent of patients experience adequate pain relief. Clearly, new therapies are needed,” explains Dr. Ruth Waterman of the Ochsner Clinic Foundation in New Orleans and lead author of the study
However, a new preparation of stem cell treatment may target the inflammation that is thought to be the main cause of neuropathy.
Dr. Waterman recently collaborated with other researchers including Dr. Aline Betancourt from Tulane University’s Center for Stem Cell Research and Regenerative Medicine to develop a new stem cell treatment that controls the inflammation that causes diabetic peripheral neuropathy.


Source/Read more at http://www.inquisitr.com/271921/new-stem-cell-treatment-reduces-diabetic-peripheral-neuropathy-inflammation-benefit-diabetics-study/#DqmDq7k14vxzZszY.99